Abstract
Major depressive disorders are leading causes of disability worldwide, yet many people remain undiagnosed, are misdiagnosed, and/or ineffectively treated. Diagnosis relies on the clinical assessment of symptoms, and no molecular diagnostic test is available. Epigenetic events and among them RNA editing modifications have been associated with neuropsychiatric disorders and form the molecular interface between genome and environment. The aim of this study is the identification of a specific RNA editing signature in blood of depressed patients
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
